P2RY12 and peripheral arterial disease: Patients with progression were older, less often male, more often PAD and AF, had higher blood urea nitrogen and uric acid levels and lower hemoglobin, and used P2Y12 inhibitors, loop diuretics, and statins more frequently than those without progression.